Joseph S. Stauffer Chair of Basic Oncology, and Associate Dean Research, Faculty of Health Sciences, Queen's University
Vice-President, Research Development, Kingston General Hospital

A graduate of Sheffield University in England, Dr. Deeley was recruited from the US National Cancer Institute to Queen's University in 1980 as an Associate Professor of Biochemistry.  During his 10 years at the US NCI, he established an international reputation in the area of gene regulation and published some of the earliest studies applying genetic engineering techniques to the discovery and characterization of novel genes.  He was recruited to Queen's University as the recipient of a Medical Research Council Development Award and was subsequently awarded a Terry Fox Team Development Award from the National Cancer Institute of Canada.  In 1987, Dr. Deeley was appointed as the first holder of the Joseph S. Stauffer Chair and Director of the Cancer Research Laboratories, and in August 2003 he was appointed as Director of the newly established Cancer Research Institute at Queen's.  From 1998 to 2007 Dr. Deeley also held the position of Director of the Division of Research for Cancer Care Ontario.  He is currently a Professor in the Departments of Pathology & Molecular Medicine, Biochemistry and Oncology at Queen's University, and in January 2007 he began his appointment as the Associate Dean (Research) in the Faculty of Health Sciences, and VP Research Development at Kingston General Hospital.

Dr. Deeley's major research interest lies in understanding how cancer cells become resistant to many chemotherapeutic drugs and he is co-discoverer of a human protein, MRP1, that is capable of pumping a variety of drugs out of both cancer and normal cells.  He has maintained an active, internationally recognized research program that has been funded continuously since his arrival in Canada by the Canadian Institutes of Health Research, the National Cancer Institute of Canada, the Heart and Stroke Foundation of Ontario and industry.  He has extensive experience with research funding agencies and has been involved in both provincial and national cancer control research initiatives.  Over the course of his career, Dr. Deeley has published approximately 180 research papers, reviews and book chapters.  He is also co-inventor on a number of patents held by the University related to the discovery of MRP1.  In 2005, Dr. Deeley was co-recipient of the Robert L. Noble Prize presented jointly by the National Cancer Institute of Canada and the Canadian Cancer Society for outstanding achievements in cancer research, and in 2007 was co-recipient of the National Cancer Institute of Canada's Diamond Jubilee Award for "outstanding impact and contribution to the field of cancer research, specifically the paradigm-shifting discoveries related to our better understanding of resistance to cancer treatment".